Brown Advisory’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$161M Buy
1,341,293
+36,367
+3% +$4.2M 0.27% 80
2025
Q4
$137M Buy
1,304,926
+36,941
+3% +$3.47M 0.19% 91
2025
Q3
$106M Buy
1,267,985
+912
+0.1% +$75.1K 0.14% 117
2025
Q2
$100M Sell
1,267,073
-22,392
-2% -$1.78M 0.13% 115
2025
Q1
$116M Sell
1,289,465
-1,031,193
-44% -$96.3M 0.17% 103
2024
Q4
$231M Sell
2,320,658
-535,988
-19% -$55.3M 0.29% 71
2024
Q3
$324M Buy
2,856,646
+263,063
+10% +$31.3M 0.41% 58
2024
Q2
$321M Buy
2,593,583
+98,691
+4% +$12.7M 0.42% 54
2024
Q1
$329M Sell
2,494,892
-41,811
-2% -$5.15M 0.44% 56
2023
Q4
$277M Sell
2,536,703
-92,608
-4% -$9.61M 0.39% 61
2023
Q3
$271M Buy
2,629,311
+41,515
+2% +$4.47M 0.44% 57
2023
Q2
$299M Sell
2,587,796
-16,389
-0.6% -$1.86M 0.47% 56
2023
Q1
$277M Buy
2,604,185
+6,561
+0.3% +$708K 0.47% 53
2022
Q4
$288M Sell
2,597,624
-214,437
-8% -$21.9M 0.54% 50
2022
Q3
$242M Buy
2,812,061
+24,608
+0.9% +$2.2M 0.47% 56
2022
Q2
$254M Buy
2,787,453
+14,213
+0.5% +$1.26M 0.48% 55
2022
Q1
$228M Sell
2,773,240
-355,193
-11% -$28M 0.34% 68
2021
Q4
$240M Buy
3,128,433
+594,183
+23% +$47.3M 0.3% 75
2021
Q3
$190M Buy
2,534,250
+209,604
+9% +$15.9M 0.28% 78
2021
Q2
$181M Buy
2,324,646
+193,795
+9% +$14.4M 0.27% 81
2021
Q1
$157M Buy
2,130,851
+220,672
+12% +$16.3M 0.27% 82
2020
Q4
$149M Buy
1,910,179
+2,357
+0.1% +$180K 0.26% 83
2020
Q3
$151M Buy
1,907,822
+146,077
+8% +$11.4M 0.31% 75
2020
Q2
$130M Buy
1,761,745
+20,660
+1% +$1.56M 0.3% 77
2020
Q1
$128M Sell
1,741,085
-8,084
-0.5% -$635K 0.39% 57
2019
Q4
$152M Sell
1,749,169
-8,809
-0.5% -$724K 0.39% 56
2019
Q3
$141M Sell
1,757,978
-18,846
-1% -$1.51M 0.4% 57
2019
Q2
$142M Sell
1,776,824
-342,862
-16% -$26.3M 0.41% 56
2019
Q1
$168M Sell
2,119,686
-3,839
-0.2% -$287K 0.48% 52
2018
Q4
$155M Sell
2,123,525
-10,840
-0.5% -$765K 0.52% 48
2018
Q3
$144M Sell
2,134,365
-19,167
-0.9% -$1.22M 0.41% 54
2018
Q2
$125M Buy
2,153,532
+82,959
+4% +$4.68M 0.38% 56
2018
Q1
$108M Buy
2,070,573
+14,925
+0.7% +$806K 0.35% 61
2017
Q4
$110M Sell
2,055,648
-93,993
-4% -$5.21M 0.35% 64
2017
Q3
$131M Sell
2,149,641
-333,129
-13% -$20.2M 0.44% 57
2017
Q2
$152M Buy
2,482,770
+316,247
+15% +$19.3M 0.46% 56
2017
Q1
$131M Sell
2,166,523
-145,667
-6% -$8.84M 0.45% 54
2016
Q4
$130M Buy
2,312,190
+116,381
+5% +$6.81M 0.46% 54
2016
Q3
$131M Sell
2,195,809
-52,013
-2% -$3.04M 0.45% 56
2016
Q2
$124M Sell
2,247,822
-21,299
-0.9% -$1.13M 0.43% 57
2016
Q1
$115M Sell
2,269,121
-8,536
-0.4% -$418K 0.4% 60
2015
Q4
$115M Sell
2,277,657
-26,934
-1% -$1.36M 0.39% 56
2015
Q3
$109M Buy
2,304,591
+20,655
+0.9% +$1.1M 0.39% 54
2015
Q2
$124M Sell
2,283,936
-16,481
-0.7% -$924K 0.4% 52
2015
Q1
$126M Sell
2,300,417
-101,385
-4% -$5.74M 0.4% 50
2014
Q4
$130M Sell
2,401,802
-185,949
-7% -$10.4M 0.41% 49
2014
Q3
$146M Buy
2,587,751
+101,737
+4% +$5.71M 0.47% 45
2014
Q2
$137M Sell
2,486,014
-38,814
-2% -$2.12M 0.43% 42
2014
Q1
$137M Buy
2,524,828
+7,010
+0.3% +$363K 0.44% 41
2013
Q4
$120M Sell
2,517,818
-489,970
-16% -$22.4M 0.39% 41
2013
Q3
$137M Buy
3,007,788
+22,738
+0.8% +$1.04M 0.49% 39
2013
Q2
$132M Buy
+2,985,050
New +$133M 0.53% 38

Other funds holding MRK

Brown Advisory's MRK Position: Q1 2026 in Review

Brown Advisory increased its Merck (MRK) stake by 2.8% in Q1 2026, buying an estimated $4.2M and bringing the position to 1,341,293 shares worth $161M. The position accounts for 0.27% of the portfolio, ranked #80.

Brown Advisory first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $329M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Brown Advisory held 1,341,293 shares of Merck worth $161M as of Q1 2026.
  • Brown Advisory bought 36,367 Merck shares in Q1 2026, an estimated $4.2M.
  • Merck made up 0.27% of Brown Advisory's portfolio in Q1 2026, its #80 holding.
  • Brown Advisory first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's Merck position peaked at $329M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.